Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | |
| Sales | 1,300 | 1,370 | 26,090 |
| Cost of Goods | 460 | 520 | 15,780 |
| Gross Profit | 840 | 850 | 10,300 |
| Operating Expenses | 3,450 | 3,120 | 21,020 |
| Operating Income | -2,150 | -1,750 | -9,930 |
| Interest Expense | 5 | 6 | 40 |
| Other Income | -5 | -224 | -960 |
| Pre-tax Income | -2,160 | -1,980 | -10,930 |
| Income Tax | 0 | 0 | 370 |
| Net Income Continuous | -2,160 | -1,980 | -11,300 |
| Net Income | $-2,160 | $-1,980 | $-11,300 |
| EPS Basic Total Ops | -17.03 | -17.73 | N/A |
| EPS Basic Continuous Ops | -17.03 | -17.73 | N/A |
| EBITDA(a) | $-1,730 | $-1,370 | $-8,630 |